IRCT20200407046981N29尚未招募未知
Comparative bioequivalence study of the Amlodipine 5-mg/Valsartan 160-mg tablet manufactured by Behestan Pharmaceutical Company versus Exforege® (Novartis).
Behestan Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Male
入选标准
- •The weight limit of each volunteer should be between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
- •Candidates who have consented to the consent form.
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Amlodipine/Valsartan or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Regular smoker who smokes more than ten cigarettes daily.
- •Taking any medicine during two weeks before dosing.
研究者
相似试验
招募中
不适用
Bioequivalence study of Amlodipine 10 mg + Valsartan 160 mg film coated tablet in 24 healthy male under fasting conditionsBioequivalence investigation of the generic Actover. Amlodipine 10 mg + Valsartan 160 mg film coated tablet with brand EXFORGE® NOVARTIS Tablet..IRCT20180620040164N20Actover Pharmaceutical Co.24
已完成
不适用
Comparative in vivo evaluation of 2 Amlodipine 10/Valsartan160 mg Tablet formulations.IRCT20180620040164N36Karen Pharma and Food Supplement Co.24
招募中
Unknown
Bioequivalence study of Amlodipine/Valsartan tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N54Tabriz University of Medical Sciences24
已完成
4 期
Comparative study of pharmacokinetics of amlodipine besilate oral liquid and tablets in healthy Dutch volunteershigh blood pressure10057166HypertensionNL-OMON36940Erasmus MC, Universitair Medisch Centrum Rotterdam12
进行中（未招募）
不适用
Comparison of the pharmacokinetics of amlodipine besilate oral liquid and tabletsHypertensionEUCTR2012-004065-41-NLErasmus Medical Centre